Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation and Other Benefit Plans - FV Assumptions (Details)

v3.23.1
Stock Based Compensation and Other Benefit Plans - FV Assumptions (Details) - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Weighted average assumptions    
Number of shares, Granted 725,000  
Exercise price (in dollars per share) $ 23.74  
Weighted-average grant-date fair value (in dollars per share)   $ 12.64
2010 Plan    
Weighted average assumptions    
Number of shares, Granted 0  
Weighted-average grant-date fair value (in dollars per share) $ 12.64  
Stock Option Inducement Award, Exercise price of $18.66 per share    
Weighted average assumptions    
Number of shares, Granted   0
Exercise price (in dollars per share) 18.66  
Weighted-average grant-date fair value (in dollars per share) 11.91  
Stock Option Inducement Award, Exercise price of $30.00 per share    
Weighted average assumptions    
Number of shares, Granted   0
Exercise price (in dollars per share) 30.00  
Weighted-average grant-date fair value (in dollars per share) $ 14.68  
Stock Options | 2010 Plan    
Weighted average assumptions    
Dividend yield   0.00%
Expected volatility   70.00%
Risk-free interest rate   1.89%
Expected term   5 years 7 months 28 days
Stock Options | Stock Option Inducement Award, Exercise price of $18.66 per share    
Weighted average assumptions    
Dividend yield 0.00%  
Expected volatility 69.00%  
Risk-free interest rate 3.92%  
Expected term 5 years 9 months 14 days  
Stock Options | Stock Option Inducement Award, Exercise price of $30.00 per share    
Weighted average assumptions    
Dividend yield 0.00%  
Expected volatility 91.00%  
Risk-free interest rate 3.86%  
Expected term 8 years 3 days